LOCUS       NP_000859                458 aa                     PRI 03-MAY-2014
DEFINITION  5-hydroxytryptamine receptor 2C isoform a precursor [Homo sapiens].
ACCESSION   NP_000859
VERSION     NP_000859.1  GI:4504541
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 458)
  AUTHORS   Assetta B, Maginnis MS, Gracia Ahufinger I, Haley SA, Gee GV, Nelson
            CD, O'Hara BA, Allen Ramdial SA and Atwood WJ.
  TITLE     5-HT2 receptors facilitate JC polyomavirus entry
  JOURNAL   J. Virol. 87 (24), 13490-13498 (2013)
   PUBMED   24089568
  REMARK    GeneRIF: 5-HT2AR, 5-HT2BR, and 5-HT2CR expression in HEK293A cells
            significantly increases susceptibility to JCPyV infection.
REFERENCE   2  (residues 1 to 458)
  AUTHORS   Knol W, van Marum RJ, Jansen PA, Strengman E, Al Hadithy AF,
            Wilffert B, Schobben AF, Ophoff RA and Egberts TC.
  TITLE     Genetic variation and the risk of haloperidol-related parkinsonism
            in elderly patients: a candidate gene approach
  JOURNAL   J Clin Psychopharmacol 33 (3), 405-410 (2013)
   PUBMED   23609402
  REMARK    GeneRIF: this study suggests that carriership of the j759 T allele
            of the HTR2C gene in females may be protective against development
            of parkinsonism in elderly patients during treatment with
            haloperidol
REFERENCE   3  (residues 1 to 458)
  AUTHORS   Yang HY, Tae J, Seo YW, Kim YJ, Im HY, Choi GD, Cho H, Park WK, Kwon
            OS, Cho YS, Ko M, Jang H, Lee J, Choi K, Kim CH, Lee J and Pae AN.
  TITLE     Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C)
            receptor ligands for the treatment of obesity
  JOURNAL   Eur J Med Chem 63, 558-569 (2013)
   PUBMED   23537943
  REMARK    GeneRIF: Data indicate that
            2-Benzyl-N-(3-chlorophenyl)-6,7,8,9-tetrahydro-5H-pyrimido[4,
            5-d]azepine-4-amine as the most potent 5-HT2A and 5-HT2C ligand in
            vitro and in vivo.
REFERENCE   4  (residues 1 to 458)
  AUTHORS   Tang WK, Tang N, Liao CD, Liang HJ, Mok VC, Ungvari GS and Wong KS.
  TITLE     Serotonin receptor 2C gene polymorphism associated with post-stroke
            depression in Chinese patients
  JOURNAL   Genet. Mol. Res. 12 (2), 1546-1553 (2013)
   PUBMED   23765961
  REMARK    GeneRIF: Genetic variation in HTR2C receptors appears to be involved
            in the pathogenesis of post-stroke depression in Chinese males.
            Publication Status: Online-Only
REFERENCE   5  (residues 1 to 458)
  AUTHORS   McGrew L, Price RD, Hackler E, Chang MS and Sanders-Bush E.
  TITLE     RNA editing of the human serotonin 5-HT2C receptor disrupts
            transactivation of the small G-protein RhoA
  JOURNAL   Mol. Pharmacol. 65 (1), 252-256 (2004)
   PUBMED   14722258
  REMARK    GeneRIF: RNA editing represents a novel mechanism for regulating
            5-HT2C receptor signaling to pathways linked to actin cytoskeletal
            organization and regulated exocytosis.
REFERENCE   6
  AUTHORS   Parker,L.L., Backstrom,J.R., Sanders-Bush,E. and Shieh,B.H.
  TITLE     Agonist-induced phosphorylation of the serotonin 5-HT2C receptor
            regulates its interaction with multiple PDZ protein 1
  JOURNAL   J. Biol. Chem. 278 (24), 21576-21583 (2003)
   PUBMED   12682077
REFERENCE   7
  AUTHORS   Backstrom,J.R., Price,R.D., Reasoner,D.T. and Sanders-Bush,E.
  TITLE     Deletion of the serotonin 5-HT2C receptor PDZ recognition motif
            prevents receptor phosphorylation and delays resensitization of
            receptor responses
  JOURNAL   J. Biol. Chem. 275 (31), 23620-23626 (2000)
   PUBMED   10816555
REFERENCE   8  (residues 1 to 458)
  AUTHORS   Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E
            and Emeson RB.
  TITLE     Regulation of serotonin-2C receptor G-protein coupling by RNA
            editing
  JOURNAL   Nature 387 (6630), 303-308 (1997)
   PUBMED   9153397
REFERENCE   9  (residues 1 to 458)
  AUTHORS   Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P,
            Chan HW and Eglen RM.
  TITLE     The pharmacology and distribution of human 5-hydroxytryptamine2B
            (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C
            receptors
  JOURNAL   Br. J. Pharmacol. 115 (4), 622-628 (1995)
   PUBMED   7582481
REFERENCE   10  (residues 1 to 458)
  AUTHORS   Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH, Virkkunen M,
            Weight F, Linnoila M and Goldman D.
  TITLE     Identification, expression, and pharmacology of a Cys23-Ser23
            substitution in the human 5-HT2c receptor gene (HTR2C)
  JOURNAL   Genomics 27 (2), 274-279 (1995)
   PUBMED   7557992
REFERENCE   11  (residues 1 to 458)
  AUTHORS   Milatovich A, Hsieh CL, Bonaminio G, Tecott L, Julius D and Francke
            U.
  TITLE     Serotonin receptor 1c gene assigned to X chromosome in human (band
            q24) and mouse (bands D-F4)
  JOURNAL   Hum. Mol. Genet. 1 (9), 681-684 (1992)
   PUBMED   1302605
REFERENCE   12  (residues 1 to 458)
  AUTHORS   Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M and Felder
            S.
  TITLE     Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes
  JOURNAL   Biochem. Biophys. Res. Commun. 181 (3), 1469-1478 (1991)
   PUBMED   1722404
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from U49516.1 and BC028688.1.
            This sequence is a reference standard in the RefSeqGene project.
            Summary: Serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter,
            elicits a wide array of physiological effects by binding to several
            receptor subtypes, including the 5-HT2 family of
            seven-transmembrane-spanning, G-protein-coupled receptors, which
            activate phospholipase C and D signaling pathways. This gene
            encodes the 2C subtype of serotonin receptor and its mRNA is
            subject to multiple RNA editing events, where genomically encoded
            adenosine residues are converted to inosines. RNA editing is
            predicted to alter amino acids within the second intracellular loop
            of the 5-HT2C receptor and generate receptor isoforms that differ
            in their ability to interact with G proteins and the activation of
            phospholipase C and D signaling cascades, thus modulating
            serotonergic neurotransmission in the central nervous system.
            Studies in humans have reported abnormalities in patterns of 5-HT2C
            editing in depressed suicide victims. Three transcript variants
            encoding two different isoforms have been found for this gene.
            [provided by RefSeq, Feb 2012].
            Transcript Variant: This variant (2) differs in the 5' UTR compared
            to variant 1. Variants 1 and 2 both encode the same isoform (a).
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: U49516.1 [ECO:0000332]
            RNAseq introns              :: mixed/partial sample support
            ERS025085 [ECO:0000350]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            undergoes RNA editing :: PMID: 14722258, 9153397
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..458
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="X"
                     /map="Xq24"
     Protein         1..458
                     /note="serotonin 5-HT-2C receptor; serotonin receptor 2C;
                     5-HT1C; 5-HT-1C; 5-hydroxytryptamine receptor 1C;
                     5-hydroxytryptamine receptor-1c"
                     /product="5-hydroxytryptamine receptor 2C isoform a
                     precursor"
     sig_peptide     1..32
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /calculated_mol_wt="3503"
     mat_peptide     33..458
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /product="5-hydroxytryptamine receptor 2C"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /calculated_mol_wt="48336"
     Site            53..78
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          73..>243
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          76..368
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            90..110
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            128..150
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          134..139
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Region          151..153
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="DRY motif, important for ligand-induced
                     conformation changes (By similarity)"
     Site            171..193
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            214..235
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            312..333
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          324..328
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            349..371
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          364..368
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="NPxxY motif, important for ligand-induced
                     conformation changes and signaling (By similarity)"
     Region          456..458
                     /note="propagated from UniProtKB/Swiss-Prot (P28335.1)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="PDZ-binding"
     Site            456
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Site            457
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /citation="[7]"
                     /site_type="phosphorylation"
     CDS             1..458
                     /note="isoform a precursor is encoded by transcript variant
                     2"
                     /coded_by="NM_000868.2:729..2105"
                     /gene="HTR2C"
                     /gene_synonym="5-HT2C; 5-HTR2C; 5HTR2C; HTR1C"
                     /db_xref="CCDS:CCDS14564.1"
                     /db_xref="GeneID:3358"
                     /db_xref="HGNC:HGNC:5295"
                     /db_xref="HPRD:02429"
                     /db_xref="MIM:312861"
ORIGIN
        1 mvnlrnavhs flvhligllv wqcdisvspv aaivtdifnt sdggrfkfpd gvqnwpalsi
       61 viiiimtigg nilvimavsm ekklhnatny flmslaiadm lvgllvmpls llailydyvw
      121 plprylcpvw isldvlfsta simhlcaisl dryvairnpi ehsrfnsrtk aimkiaivwa
      181 isigvsvpip viglrdeekv fvnnttcvln dpnfvligsf vaffipltim vitycltiyv
      241 lrrqalmllh ghteeppgls ldflkcckrn taeeensanp nqdqnarrrk kkerrprgtm
      301 qainnerkas kvlgivffvf limwcpffit nilsvlceks cnqklmekll nvfvwigyvc
      361 sginplvytl fnkiyrrafs nylrcnykve kkppvrqipr vaatalsgre lnvniyrhtn
      421 epviekasdn epgiemqven lelpvnpssv vserissv
//
